# MAGEA8

## Overview
MAGEA8 is a gene that encodes the protein MAGE family member A8, which is part of the melanoma-associated antigen (MAGE) family. This family of proteins is characterized by their role in various cellular processes, including cell cycle regulation and apoptosis. MAGEA8, like other members of the MAGEA family, is typically expressed in a restricted manner in normal tissues but is aberrantly overexpressed in several types of cancers, including transitional cell carcinoma of the bladder. The protein encoded by MAGEA8 is implicated in oncogenic processes, contributing to tumorigenesis and cancer progression through mechanisms such as increased cellular proliferation and resistance to chemotherapy (BarHaim2004MAGEA8; Colemon2020DNA). Due to its cancer-specific expression pattern, MAGEA8 is being explored as a potential target for cancer immunotherapy, with its derived peptides serving as tumor-associated antigens capable of eliciting immune responses (BarHaim2004MAGEA8).

## Structure


## Clinical Significance
MAGEA8 is overexpressed in various cancers, including transitional cell carcinoma (TCC) of the bladder, where it is amplified by 7.8-fold compared to normal bladder tissue. This overexpression is observed in a significant number of tumor samples and is absent in normal tissues, making MAGEA8 a potential target for cancer immunotherapy (BarHaim2004MAGEA8). The gene's expression is associated with increased cellular proliferation and resistance to chemotherapeutic agents, contributing to cancer persistence and poor prognosis (Colemon2020DNA). 

In bladder cancer, MAGEA8 is part of the MAGEA family, which shows genomic alterations such as gene amplification, suggesting a role in tumorigenesis (Verma2024Melanoma). MAGEA8-derived peptides have been identified as tumor-associated antigens, capable of eliciting immune responses, indicating their potential use in immunotherapy for TCC (BarHaim2004MAGEA8). 

The MAGEA family, including MAGEA8, is associated with poor prognosis in several cancers, as high expression levels are linked to cancer progression and metastasis (Poojary2020Prognostic). These characteristics make MAGEA8 a significant focus for therapeutic strategies targeting cancer cells.


## References


[1. (BarHaim2004MAGEA8) E Bar-Haim, A Paz, A Machlenkin, D Hazzan, B Tirosh, L Carmon, B Brenner, E Vadai, O Mor, A Stein, F A Lemonnier, E Tzehoval, and L Eisenbach. Mage-a8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides. British Journal of Cancer, 91(2):398–407, June 2004. URL: http://dx.doi.org/10.1038/sj.bjc.6601968, doi:10.1038/sj.bjc.6601968. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.bjc.6601968)

[2. (Verma2024Melanoma) Shiv Verma, Diya Swain, Prem Prakash Kushwaha, Smit Brahmbhatt, Karishma Gupta, Debasish Sundi, and Sanjay Gupta. Melanoma antigen family a (mage a) as promising biomarkers and therapeutic targets in bladder cancer. Cancers, 16(2):246, January 2024. URL: http://dx.doi.org/10.3390/cancers16020246, doi:10.3390/cancers16020246. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers16020246)

[3. (Poojary2020Prognostic) Manish Poojary, Padacherri Vethil Jishnu, and Shama Prasada Kabekkodu. Prognostic value of melanoma-associated antigen-a (mage-a) gene expression in various human cancers: a systematic review and meta-analysis of 7428 patients and 44 studies. Molecular Diagnosis &amp; Therapy, 24(5):537–555, June 2020. URL: http://dx.doi.org/10.1007/s40291-020-00476-5, doi:10.1007/s40291-020-00476-5. This article has 20 citations.](https://doi.org/10.1007/s40291-020-00476-5)

[4. (Colemon2020DNA) Ashley Colemon, Taylor M. Harris, and Saumya Ramanathan. Dna hypomethylation drives changes in mage-a gene expression resulting in alteration of proliferative status of cells. Genes and Environment, July 2020. URL: http://dx.doi.org/10.1186/s41021-020-00162-2, doi:10.1186/s41021-020-00162-2. This article has 10 citations.](https://doi.org/10.1186/s41021-020-00162-2)